Biologics target and suppress specific drivers of inflammation and work well in some patients to treat the symptoms of nasal polyposis.

The reboot approach significantly reduced nasal polyp recurrence for 30 months postoperatively compared to the current mucosa-sparing approach.
Can the use of steroid eluting stents play a positive role in treating post-surgery recurrent nasal polyposis in the clinic?